Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Lesinurad
Drug ID BADD_D01256
Description Lesinurad is an oral uric acid transporter 1 (URAT1) inhibitor indicated for the treatment of hyperuricemia associated with gout. It reduces serum uric acid concentration through the inhibition of URAT1, an enzyme responsible for reuptake of uric acid from the renal tubule, and OAT4, another uric acid transporter associated with diuretic-induced hyperuricemia. Marketed as the product Zurampic, it is indicated for use in combination with a xanthine oxidase inhibitor for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid levels with a xanthine oxidase inhibitor alone. In August 2017, a combination oral therapy consisting of lesinurad and [DB00437] was FDA-approved under the brand name Duzallo indicated for the treatment of gout-related hyperuricemia in patients with uncontrolled gout.
Indications and Usage For use, in combination with a xanthine oxidase inhibitor, for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid levels with a xanthine oxidase inhibitor alone.
Marketing Status approved; investigational
ATC Code M04AB05
DrugBank ID DB11560
KEGG ID D09921
MeSH ID C000593471
PubChem ID 53465279
TTD Drug ID D0C3SW
NDC Product Code 72640-006
UNII 09ERP08I3W
Synonyms lesinurad | ((5-bromo-4-(4-cyclopropyl-1-naphthyl)-4H-1,2,4-triazol-3-yl)sulfanyl)acetic acid | RDEA594 | Zurampic
Chemical Information
Molecular Formula C17H14BrN3O2S
CAS Registry Number 878672-00-5
SMILES C1CC1C2=CC=C(C3=CC=CC=C23)N4C(=NN=C4Br)SCC(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Blood creatinine increased13.13.01.004--
Cardiovascular disorder02.11.01.010; 24.03.02.009--Not Available
Gastrooesophageal reflux disease07.02.02.003--
Headache17.14.01.001--
Influenza22.07.02.001; 11.05.03.001--Not Available
Nephrolithiasis20.04.01.002--
Nephropathy20.05.03.001--Not Available
Renal failure20.01.03.005--Not Available
The 1th Page    1    Total 1 Pages